³í¹®
¡Ý ±¹³»ÇÐȸÁö ¹ßÇ¥³í¹®
1. The Effectiveness of (1,3)-¥â-D-Glucan assay for Diagnosis of Invasive Fungal Infections in Patients with Burn Injury (2019), Korean J Healthc Assoc Infect Control Prev.
2. Performance Evaluation of the Autokit Total Ketone Bodies (2017), Journal of Laboratory Medicine and Quality Assurance
3. Effects of pronase treatment on flowcytometric crossmatch test (2016), Journal of Laboratory Medicine and Quality Assurance
¡Ý ±¹Á¦ÇÐȸÁö ¹ßÇ¥³í¹®
1. Lee N, Kim SM, Lee Y, Jeong D, Yun J, Ryu S, et al. Prognostic value of integrated cytogenetic, somatic variation, and copy number variation analyses in Korean patients with newly diagnosed multiple myeloma. PloS one. 2021;16(2):e0246322.
2. Lee N, Kym D. Clinical Usefulness of Serum (1,3)-¥â-D-glucan to predict invasive candidiasis in patients with severe burn trauma. Journal of microbiology, immunology, and infection 2021.
3. Jeong S, Lee N, Lee SK, Cho EJ, Hyun J, Park MJ, et al. Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers. Journal of clinical microbiology. 2021:Jcm0110521.
4. Lee N, Jeong S, Park MJ, Song W. Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity. PloS one. 2021;16(6):e0253889.
5. Lee N, Nam M, Roh EY, Shin S, Park KU, Song EY. Associations of Anti-MHC Class I-related Chain A (MICA) Antibodies with Renal Allograft Outcomes. Ann Clin Lab Sci 2020;50:247-252.
6. Lee N and Lee BC. Incidence of Severe Chronic Neutropenia in South Korea and Related Clinical Manifestations: A National Health Insurance Database Study. Medicina (Kaunas) 2020;56.
7. Lee N, Park HS, In JW, Roh EY, Shin S, Park KU, et al. Association of HLA Types with Non-Specific Binding of Negative Control Beads in Luminex Panel Reactive Antibody (PRA) Screening Assay. Clin Lab 2017;63:169-174.
8. Lee N, Moon SY, Lee JH, Park HK, Kong SY, Bang SM, et al. Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma. Blood Cancer J 2017;7:e530.
9. Lee N, In JW, Kim H, Roh EY, Shin S, Park KU, et al. Comparison of Flow-cytometric Antibody Secreting Cell Assay and Mabtech Immunoglobulin ELISpot Assay. Transplant Proc 2017;49:963-966.
10. Lee N, Kim JE, Yoo HJ, Gu J, Kim H, Chung J, et al. Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency. Ann Clin Lab Sci 2016;46:696-700.
11.Lee N, Kim JE, Gu JY, Yoo HJ, Kim I, Yoon SS, et al. Protein Z efficiently depletes thrombin generation in disseminated intravascular coagulation with poor prognosis. Blood Coagul Fibrinolysis 2016;27:84-89.
12. Lee N, Jun JH, Lee DS. Decreased sensitivity of the automatic white precursor cell channel (WPC) for blast flagging in patients with leukopenia. Clin Biochem 2016;49:675-681.
13. Lee N, Lee H, Moon SY, Sohn JY, Hwang SM, Yoon OJ, et al. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma. Ann Lab Med 2015;35:563-569.